biz2credit logo.png
Biz2Credit to Host Online Town Hall with U.S. Senator John Hickenlooper on “Small Business, Inflation, and the Economy in 2023”
January 12, 2023 12:32 ET | Biz2Credit
NEW YORK, Jan. 12, 2023 (GLOBE NEWSWIRE) -- In its first online Town Hall of 2023, Biz2Credit will host U.S. Senator John Hickenlooper (D-CO) on Wednesday, Jan. 18, from 1:00 to 2:00 p.m. (EST) to...
Federal Tax Credits Logo.png
Federal Tax Credits Offers Help And Advice To Companies Who Have Been Affected By The Coronavirus Pandemic On Obtaining The Employee Retention Tax Credit
January 10, 2023 09:00 ET | Federal Tax Credits
La Center, Washington, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Federal Tax Credits is a company that helps small to medium-sized US businesses get the ERTC Tax Credits. Employee Retention Tax Credit...
ExeVir Bio ontvangt
ExeVir Bio ontvangt 25 miljoen euro financiering met durfkapitaal van de Europese Investeringsbank
January 09, 2023 02:00 ET | ExeVir Bio
Financiering voor de verdere wetenschappelijke ontwikkeling van innovatieve COVID-19-behandelingen met nanobody’s voor de bescherming van hoog risicogroepen met verminderde immuniteit Het bedrijf...
ExeVir logo.png
ExeVir Bio contracte un prêt d’amorçage-investissement de 25 millions d’euros auprès de la Banque européenne d’investissement
January 09, 2023 02:00 ET | ExeVir Bio
Financer le développement scientifique de traitements innovants contre le COVID-19 basés sur des nanocorps, visant à protéger des personnes immunodéprimées à haut risque L’entreprise développe des...
ExeVir logo.png
ExeVir Bio secures EUR 25 million venture debt financing from the European Investment Bank
January 09, 2023 02:00 ET | ExeVir Bio
Financing to advance the scientific development of innovative COVID-19 nanobody treatments focused on protecting high-risk immunocompromised individuals Company developing highly potent antibodies...
InflaRx on large white.jpg
InflaRx Provides Update on Planned Phase III Study Design in Pyoderma Gangrenosum with Vilobelimab and Status of its EUA Application in Critically Ill COVID-19 Patients
January 05, 2023 07:30 ET | InflaRx N.V.
Multi-national, randomized, controlled adaptive Phase III design for vilobelimab in ulcerative pyoderma gangrenosum (PG) Trial size to be adapted upon interim analysis with planned total patient...
InflaRx on large white.jpg
InflaRx Announces Amendment of Co-Development Agreement and Additional Equity Investment by Staidson in Connection with Regulatory Filing in China for Anti-C5a-Antibody for Treatment of COVID-19
December 21, 2022 07:30 ET | InflaRx N.V.
InflaRx will provide access to certain clinical, manufacturing and regulatory documentation for vilobelimab to facilitate STS’s regulatory filings in ChinaSTS plans to request regulatory approval in...
New to The Street / Newsmax TV Announces Episode #417, Nine Corporate Interviews for this Week's TV Broadcast, Sunday, December 18, 2022, Hour Slot 10-11 AM ET
December 16, 2022 09:31 ET | FMW Media Works Corp
NEW YORK, Dec. 16, 2022 (GLOBE NEWSWIRE) -- FMW Media's New To The Street / Newsmax TV announces the broadcasting line-up of its nationally syndicated 1-hour TV show this Sunday, December 18, 2022,...
Simply Disc Golf Helps New Players In Breakout Covid Sport
December 14, 2022 09:00 ET | Simply Disc Golf
Fairfield, California, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Simply Disc Golf is made up of a group of passionate disc golfers who love writing, researching, and sharing their insights with other...
johnson fistel.jpg
Eiger BioPharmaceuticals Class Action Deadline Alert: Johnson Fistel Encourages Shareholders to Submit Their EIGR Losses
December 05, 2022 08:16 ET | Johnson Fistel, LLP
SAN DIEGO, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Eiger BioPharmaceuticals,...